Abstract
Microfluidic image cytometry (MIC) technology has been developed and utilized to perform quantitative/multiparameter immunocytochemistry (ICC), enabling parallel detection of multiple proteins in individual cells. A number of glioblastoma cell lines, as well as genetically modified and primary glioblastoma cells were utilized to validate the MIC technology. The dynamic changes of the proteins associated with the PI3K signaling pathway upon the exposure to exogenous stimuli (e.g., growth factors and kinase inhibitors) can be kinetically monitored, providing a potent tool to better understand how these glioblastoma cells respond to a combination of drug treatments.
Original language | English (US) |
---|---|
Pages | 1108-1110 |
Number of pages | 3 |
State | Published - 2008 |
Event | 12th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2008 - San Diego, CA, United States Duration: Oct 12 2008 → Oct 16 2008 |
Other
Other | 12th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2008 |
---|---|
Country/Territory | United States |
City | San Diego, CA |
Period | 10/12/08 → 10/16/08 |
Keywords
- Cancer diagnostics
- Image cytometry
- Immunocytochemistry
- Signaling profile
ASJC Scopus subject areas
- Chemical Engineering (miscellaneous)
- Bioengineering